NCT07338409|Completed
Evaluation of Postoperative Outcomes and Mortality in Laparoscopic and Robotic Distal Pancreatectomy
PREINSTRUCT
Loading search results
PREINSTRUCT
Sponsor study identifier
observational
126
1 country
1
Study Start
March 4, 2025
Actual (reported)Primary Completion
June 5, 2025
Actual (reported)Study Completion
June 5, 2025
Actual (reported)Minimally invasive distal pancreatectomy can be performed using either a laparoscopic or robotic approach. These minimally invasive techniques are becoming increasingly common in the surgical treatment of both benign and malignant pancreatic lesions. They offer several advantages over traditional open surgery, such as less postoperative pain, better cosmetic results, faster recovery, less blood loss during surgery, and lower healthcare costs. However, despite these advantages, evidence comparing postoperative outcomes, particularly complications, between laparoscopic and robotic distal pancreatectomy remains limited. Previous studies suggest that robotic surgery may offer technical benefits, such as greater accuracy and precision, which could potentially result in fewer complications. However, the available literature is diverse and often based on small cohorts.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
June 5, 2025
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
March 4, 2025
Actual (reported)June 5, 2025
Actual (reported)June 5, 2025
Actual (reported)December 16, 2025
Actual (reported)January 13, 2026
Actual (reported)90-day postoperative complications
Postoperative in-hospital complications in the 90-day postoperative period
90- days postoperative
Cumulative postoperative morbidity
Patients that underwent distal pancreatectomy surgery at Jessa Hospital from 01/01/2020 up until 30/06/2025
Length of hospital stay
Time between start of surgery and discharge of hospital
Re-admissions
within 30 days of discharge
Conversion rate
Time from surgery until last follow up of the study
Mortality
Until the end of the study (31/12/2025)
All patients that underwent distal pancreatectomy surgery at Jessa Hospital from 01/01/2020 up until 31/12/2024 were included in the study.
Jessa Hospital
Hasselt, 3500, Belgium
126 participants (actual enrollment reported by the registry).
First Submitted
December 16, 2025
First Posted
January 13, 2026
Study Start
March 4, 2025
Actual (reported)Contact the study team to confirm eligibility.
Primary Completion
June 5, 2025
Actual (reported)Study Completion
June 5, 2025
Actual (reported)Last Updated
January 13, 2026
Record last verified: 2026-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: